Cite
HARVARD Citation
Andritsos, L. et al. (2018). Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Leukemia & lymphoma. 59 (4), pp. 1008-1011. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Andritsos, L. et al. (2018). Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Leukemia & lymphoma. 59 (4), pp. 1008-1011. [Online].